Bajaj Healthcare Ltd.

283.95

-16.5 (-5.5%)growUp

BAJAJHCARE Share Price
As on March 13, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap899 Cr
P/E Ratio20.89
Dividend Yield0.07 %
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open300.05
High300.4
NSE SymbolBAJAJHCARE
Close283.95
Low282.15
BSE Symbol539872
Previous Years High/Low
1 Year High745
3 Year High745
5 Year High745
1 Year Low282.15
3 Year Low263.3
5 Year Low257.45

Technicals


IndicatorsValueSignal
5-DMA304.25Bearish
10-DMA313.49Bearish
20-DMA331.92Bearish
50-DMA358.18Bearish
100-DMA395.75Bearish
200-DMA438.8Bearish

Historical Performance


1 Year
-55.1%
3 Years
-14.4%
5 Years
N/A
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:-4.8
TTM:-55.1
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a moderate PE of 20.89, suggesting fair valuation relative to earnings.
  • Over the last three years, the stock delivered a weak 3-year price CAGR of -4.8%, indicating poor shareholder returns.
  • The stock carries a beta of 1.1, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹1020 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹5426 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 427635.5
No. of Shares: 1506 (Approx)
Performance:-57.2%
P/L: ₹-572364.5
NIFTY Performance: 3.4%
1 day Top Gainers
SymbolChange%
LTTS3430.1(10%)
ACMESOLAR255.61(7%)
IFCI57.21(6%)
AIIL474.8(6%)
CHOLAHLDNG1553.9(5%)
1 Day Top Losers
SymbolChange%
CRAFTSMAN6674(-9%)
CEATLTD3470.5(-9%)
KPRMILL839.2(-8%)
LT3439(-8%)
AMBER6446(-7%)
ATGL565.9(-7%)
MRPL178.14(-7%)
PCBL253.2(-7%)

Top Performing Stocks from the same sector


Onesource Specialty Pharma Ltd.

25.8%

1491.2

1 Month Performance

Venus Remedies Ltd.

21.2%

894.45

1 Month Performance

Sakar Healthcare Ltd.

16.1%

518.75

1 Month Performance

Natco Pharma Ltd.

16%

955.85

1 Month Performance

Aurobindo Pharma Ltd.

13.2%

1296.5

1 Month Performance

JB Chemicals & Pharmaceuticals Ltd.

12.2%

2121.8

1 Month Performance

SMS Pharmaceuticals Ltd.

9.4%

368.75

1 Month Performance

Glenmark Pharmaceuticals Ltd.

8.7%

2170.7

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month